You are not logged in.
This means
you CAN ONLY VIEW reports that were published prior to Monday, February 26, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
 MIDDAY BREAKOUTS REPORT - WEDNESDAY, JUNE 23RD, 2010
Previous Mid Day Report Next Mid Day Report >>>
|
|
DOW 10289.82 -3.7 (-0.04%) | NASDAQ 2254.34 -7.46 (-0.33%) | S&P 500 1089.48 -5.83 (-0.53%)
|
Time of Screening :
6/23/2010 12:12:03 PM Report Released :
6/23/2010 1:03:40 PM
Price is:
Above 52W High and Less Than 52W High
but within 8% of the 52 Week High
Volume Is:
At least 57.5% of 50 Day Average at
the time of the screening.
More details about this report...
At around
mid-way through each trading day we run
a screen against our database of
high-ranked stocks, searching for
possible buy candidates that are trading
at or near their 52-week high on above
average volume. The results of that
screen are split into the two sections
you see below. The first, titled
"TODAY's FEATURED STOCKS" shows stocks
that our experts have recently
identified as among the strongest candidates to
consider. Stocks highlighted in yellow
are the most timely and noteworthy, so
particular attention and prompt action
may be appropriate. The second section,
titled "TODAY's BREAKOUT SCREEN" shows
the remainder of stocks meeting today's
screen parameters. Our experts have
reviewed and included notes on these
stocks as well, but found that they may
not match up as favorably.
|
|
Y - Today's strongest
candidates
highlighted
by our staff
of experts.
|
|
G - Previously featured in
this report as yellow and
now may no longer be buyable
under the guidelines.
|
|
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(50 DAV) |
52 Wk Hi
% From Hi |
Date
Featured |
Price
Featured |
Pivot Point |
|
Max Buy |
BRLI
- NASDAQ
Bio Reference Labs Inc
|
$23.00
|
+0.20
0.88%
|
$23.11
|
148,433
79.42% of 50 DAV
50 DAV is 186,900
|
$24.67
-6.77%
|
6/15/2010 |
$23.57
|
PP = $24.77
MB = $26.01 |
Most Recent Note - 6/23/2010 12:20:20 PM
Y - Consolidating in a tight range for the past 4 weeks near its 50 DMA line, still perched within close striking distance (-7%) of its all-time high.
>>> The latest Featured Stock Update with an annotated graph appeared on 6/15/2010. Click here.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
 |
Symbol - Exchange - Industry Group
Company Name |
Last |
Chg |
Day
High |
52 WK Hi |
% From Hi |
Volume
% DAV |
DAV |
BAP
- NYSE - BANKING - Foreign Regional Banks
Credicorp Ltd
|
$93.20 |
+0.20
0.22%
|
$93.51
|
$99.36
|
-6.20% |
155,374
61.80%
|
251,400
|
Most Recent Note for BAP - 6/23/2010 12:16:23 PM
Pulling back from its 52-week high toward prior chart highs in the $91 area that are an initial support level to watch above its 50 DMA line. This Peru-based Bank has a good annual earnings (the A criteria) history, however recent quarterly sales revenues comparisons have been essentially flat and earnings growth has decelerated to below the fact-based investment system's guidelines. Based on weak technical action it was removed from the Featured Stocks list on 7/08/08, and it has rebounded impressively from subsequent lows in the $30 area.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CIB
- NYSE - BANKING - Foreign Regional Banks
Bancolombia Sa Ads
|
$50.63 |
-0.57
-1.11%
|
$51.57
|
$51.96
|
-2.56% |
557,231
191.09%
|
291,600
|
Most Recent Note for CIB - 6/23/2010 12:39:33 PM
Pulling back from a new all-time high after multiple gains with above average volume helped it recently rally above resistance in the $49 area. This Colombia-based bank operating company's quarterly and annual earnings history has been erratic, with sales revenues not growing.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DFZ
- NASDAQ - CONSUMER NON-DURABLES - Textile - Apparel Footwear
R G Barry Corporation
|
$11.64 |
-0.07
-0.60%
|
$11.70
|
$12.00
|
-3.00% |
47,504
136.51%
|
34,800
|
Most Recent Note for DFZ - 6/23/2010 12:42:27 PM
Trading in a very tight range above prior chart highs for the past 3 weeks. Noted in prior mid-day reports - "Amid early-May's market weakness it briefly dove below its 50 and 200 DMA lines, then promptly rebounded. Recent quarters showed improved earnings increases but sales revenues have not shown strong increases and its annual earnings history (A criteria) has been up and down."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
EPB
- NYSE - ENERGY - Oil &; Gas Pipelines
El Paso Pipeline Partner
|
$28.50 |
+0.05
0.18%
|
$28.60
|
$30.77
|
-7.38% |
276,647
66.71%
|
414,700
|
Most Recent Note for EPB - 6/23/2010 12:48:53 PM
Holding its ground since gapping down on 6/18/10 news of a Proposed Public Offering. It recently reached new all-time highs and was noted in several mid-day reports - "master limited partnership owns and operates natural gas transportation pipelines and storage assets in the US, it has reported sales revenues and earnings increases borderline with the minimum guidelines of the fact-based investment system in recent quarterly comparisons and has a good annual earnings (A criteria) history. It completed additional Public Offerings in June '09 and Jan '10."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
EW
- NYSE - HEALTH SERVICES - Medical Appliances & Equipment
Edwards Lifesciences Cp
|
$52.13 |
-2.68
-4.89%
|
$53.70
|
$56.00
|
-6.91% |
1,022,019
108.48%
|
942,100
|
Most Recent Note for EW - 6/23/2010 12:51:54 PM
Considerable loss with higher volume after gapping down today, pulling back near its 50 DMA line. Noted in prior mid-day reports that it - "endured numerous distribution days since March yet it held up well, and on 5/28/10 its share price was impacted by a 2:1 split . The Medical - Products firm has a slow but steady annual earnings history. Quarterly sales revenues and earnings increases have been below guidelines. With respect to the N criteria, explosive sales revenues increases would be a true indication of great or growing demand for any company's products."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GOLD
- NYSE - METALS & MINING - Gold
Barrick Gold Corporation
|
$95.75 |
+0.76
0.80%
|
$96.06
|
$96.80
|
-1.08% |
674,512
58.30%
|
1,157,000
|
Most Recent Note for GOLD - 6/23/2010 12:56:19 PM
Holding its ground stubbornly after rallying to new all-time highs in the past week, having cleared the right side of a 6-month base pattern. Sales revenues and earnings increases (C criteria) in the past 3 quarterly comparisons have been greater than the +25% minimum guideline, however its up and down annual earnings (A criteria) is a concern.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SAM
- NYSE - FOOD & BEVERAGE - Beverages - Brewers
Boston Beer Company
|
$70.21 |
-1.70
-2.36%
|
$71.91
|
$74.52
|
-5.78% |
150,515
106.37%
|
141,500
|
Most Recent Note for SAM - 6/23/2010 1:00:16 PM
Pulling back today on higher volume, down for a second consecutive session after a great winning streak. It is extended from any sound base after steadily rising to new all-time high territory with 19 gains in the span of 21 sessions. This high-ranked Beverages - Alcoholic industry group leader's annual earnings (A criteria) showed a downturn in FY '08 and its sales revenues history is below the investment system guidelines. Sales revenues showed +16% improvement in the period ended March 31, 2010 versus the year ago period while the 3 latest comparisons showed earnings increases above the +25% guideline.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VRX
- NYSE - DRUGS - Drug Manufacturers - Other
Valeant Pharmaceuticals
|
$50.13 |
-0.74
-1.45%
|
$51.74
|
$51.75
|
-3.13% |
1,273,192
76.07%
|
1,673,700
|
Most Recent Note for VRX - 6/23/2010 1:03:07 PM
Touched a new 52-week high today then reversed into the red. Two consecutive gains with heavy volume followed headlines after Biovail and Valeant agreed to a $3.2 Billion merger. Noted in prior mid-day reports - "It has made steady upward progress since noted in early January 2010 after rallying straight up from the bottom of a 7-week base. Quarterly earnings increases (C criteria) have been strong and well above the +25% guideline. A downturn in FY '07 earnings tarnished its earnings track record (A criteria remains a concern)."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
We are not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to FactBasedInvesting.com c/o Premium
Member Services 665 S.E. 10 Street, Suite 201
Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.
We appreciate any feedback
members may wish to send via the inquiry form
here.
|
|
|
